Navigation Links
Mexico's expanded health insurance improves hypertension treatment
Date:11/7/2007

Mexicos new health insurance program, Seguro Popular, which was created to extend health insurance to the nations 50 million uninsured by 2010, is having a positive effect on coverage of antihypertensive treatment in that country, according to a study published in the October 27 issue of British Medical Journal. Results of the study show that adults insured through Seguro Popular are significantly more likely to receive treatment for hypertension and significantly more likely to have their blood pressure controlled than those without health insurance.

Lack of health insurance has been consistently identified as a key obstacle to hypertension treatment and Mexico is among the last of the OECD countries to guarantee health insurance for all of its citizens, said Sara N. Bleich, PhD, lead author of the study and assistant professor in the Johns Hopkins Bloomberg School of Public Healths Department of Health Policy and Management. Bleich conducted the research while completing her doctoral degree at Harvard University. The odds of receiving antihypertensive treatment were 50 percent higher for those insured through Seguro Popular than those without insurance.

The study also showed that those insured through the program had a 35-percent-higher odds of receiving treatment with blood pressure control compared to the uninsured. In addition, the impact of Seguro Popular was greatest in regions of Mexico where there were higher concentrations of health care providers.

According to Bleich, hypertension affects more than 9 million adults in Mexico. It is a risk factor for cardiovascular disease and stroke, which are among the leading causes of death in Mexico. Treatment of the disease will cost Mexico an estimated $3 billion this year.

For the study, the researchers examined national health data from 1,065 uninsured adults and compared them to an equal number of adults covered through Seguro Popular. The participants were selected from a group of 4,032 adults with hypertension.

Compared with the uninsured, those insured with Seguro Popular had higher rates of coverage for antihypertensive treatment and blood pressure control. The success of Seguro Popular should serve as an example to other developing countries looking to provide health insurance to its citizens, said Bleich.


'/>"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Related medicine news :

1. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
2. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
3. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
4. Eularis Announces New Corporate Name and Expanded Product Offerings
5. E. Coli Registry Expanded for Victims of E. Coli Poisoning from Cargill Ground Beef
6. AMDL Launches Expanded Distribution With 4th Round of Agreements Valued at $6.79 Million Annually for New Health & Beauty Product Line
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... For over twenty-four years, Doctors on Liens ... personal injury victims find high quality medical care. When the company started in 1997, ... Fast forward to present day and the now ten-page directory features a vast array of ...
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to host ... other developmental disabilities. The group, which is being launched with the help of Robbie ... share stories and advice, seek help, and continue their education on how to best ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s ... ostomy patients, standing as living proof that attitude and determination can combine into ... issues that spike around the holidays. This campaign will offer patients a new-found ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), ... Specialties, Inc. ("PSI").  The combination of Texas ... -based PSI bring together both company,s clinical expertise and ... payers an industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... MARLBOROUGH, Mass. , Dec. 2, 2016 ... announced a definitive agreement to acquire certain manufacturing assets ... NVCN ) (TSX: NVC) advanced biological tissue business, as ... a total of $75 million in cash. The Neovasc ... heart valves, including the Boston Scientific Lotus™ Valve System. ...
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
Breaking Medicine Technology: